| J3262 | Injection, tocilizumab, 1 mg | 74,210 | $10 | $371K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 44,310 | $10 | $354.5K |
| J0897 | Injection, denosumab, 1 mg | 14,640 | $20 | $263.5K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,180 | $30 | $236.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,490 | $100 | $141.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 7,210 | $10 | $79.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 320 | $70 | $21.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $100 | $18.9K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 110 | $160 | $18K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 230 | $50 | $11.3K |